arsenic trioxide has been researched along with Carcinoma in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 13 (61.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Z; Fan, C; Kong, H; Shi, J; Wang, L; Xia, K; Yan, Q; Zhang, J; Zhang, Y; Zhu, Y; Zuo, X | 1 |
| Flemington, EK; Lasky, JA; Lin, Z; Luo, F; Sides, MD; Sosulski, ML | 1 |
| Hu, J; Huang, X; Wang, X; Zhang, Y; Zhou, H; Zhou, K | 1 |
| Au, WY; Fong, BM; Lang, BH; Mao, KJ; Tam, S | 1 |
| Firkin, F | 1 |
| Hu, J; Huang, X; Wang, X; Zhang, Y; Zhou, H | 1 |
| Li, Q; Li, Y; Liu, H; Liu, R; Shen, X; Wang, W; Yu, G | 1 |
| Brossart, P; Fröhlich, E; Wahl, R | 1 |
| Geng, Y; Hou, J; Wu, DD; Xiao, YF | 1 |
| Haller, E; Mills, GB; Nanjundan, M; Patel, S; Raffoul, F; Smith, DM | 1 |
| Chang, JW; Li, YY; Wang, CH; Wang, HM; Yeh, KY | 1 |
| Cui, YH; Gu, JF; Hua, QL; Huo, XQ; Li, SQ; Li, WW; Li, XR; Liang, HJ; Lu, P; Miao, ZH; Yang, QH; Zhang, QQ | 1 |
| He, C; Jiang, H; Jiang, X; Qiao, H; Sun, X; Sun, XP; Zhang, X | 1 |
| Bauckman, KA; Dutta, PS; Kodigepalli, KM; Nanjundan, M | 1 |
| Ahmed, M; Gazelle, GS; Goldberg, SN; Horkan, C; Kruskal, JB; Liu, Z; Solazzo, SA | 1 |
| Han, K; Kang, CS; Kim, M; Kim, Y; Lee, EJ; Lim, J; Moon, Y; Pai, SH; Park, G | 1 |
| Han, B; Kakudo, K; Tang, W; Wang, X; Zhang, J; Zhang, Q; Zhou, G | 1 |
| Ai, Z; Lu, W; Qin, X | 1 |
| Ai, Z; Liu, H; Lu, W; Qin, X; Shen, Z; Sou, T; Ton, S | 1 |
| Cai, J; Chen, Y; Hu, Q; Niu, X; Shi, G; Wang, J; Wu, H; Yi, J | 1 |
| Chun, YJ; Chung, HY; Hong, SI; Kim, TH; Lee, SJ; Lee, YS; Park, IC; Park, MJ; Rhee, CH; Woo, SH | 1 |
21 other study(ies) available for arsenic trioxide and Carcinoma
| Article | Year |
|---|---|
Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Autophagy; Carcinoma; Drug Therapy, Combination; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Nude; Nanodiamonds | 2018 |
Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Disease Models, Animal; Drug Therapy, Combination; Ganciclovir; Heterografts; Humans; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oxides; Treatment Outcome; Tumor Burden | 2013 |
[Inhibitory effect of arsenic trioxide combined with cisplatin on human nasopharyngeal carcinoma xenograft and DAPK in nude mice].
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Cisplatin; Death-Associated Protein Kinases; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oxides; Xenograft Model Antitumor Assays | 2013 |
Thyroid arsenic content and papillary thyroid carcinoma arising 10 years after oral arsenic trioxide therapy for refractory acute promyelocytic leukemia.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Carcinoma, Papillary; Female; Humans; Leukemia, Promyelocytic, Acute; Neoplasms, Second Primary; Oxides; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Young Adult | 2014 |
Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide: a cause for concern?
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Carcinoma, Papillary; Female; Humans; Leukemia, Promyelocytic, Acute; Neoplasms, Second Primary; Oxides; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2014 |
[Effects of arsenic trioxide combined with cisplatin on the growth of human nasopharyngeal carcinoma cells and reversion of RASSF1A hympermethylation].
Topics: Animals; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Cisplatin; DNA Methylation; Humans; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Oxides; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2014 |
Construction of a BALB/c-Nu Mouse Model of Invasive Bladder Carcinoma and Preliminary Studies on the Treatment of Bladder Tumors through Internal Iliac Arterial Infusion of Albumin-Bound Arsenic Trioxide (As2O3).
Topics: Animals; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Disease Models, Animal; Humans; Infusions, Intra-Arterial; Mice; Mice, Inbred BALB C; Oxides; Serum Albumin, Bovine; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Iodides; Lovastatin; Neoplasm Metastasis; Oxides; Pyrazines; Sirolimus; Thymus Gland; Thyroid Neoplasms; Tretinoin | 2009 |
Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Proliferation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oxides; Stomach Neoplasms; Subcutaneous Tissue; Transplantation, Heterotopic; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells.
Topics: Acetylcysteine; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Autophagy; Autophagy-Related Protein 5; Autophagy-Related Protein 7; Beclin-1; Carcinoma; Cell Line, Tumor; Female; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Microtubule-Associated Proteins; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; Oxides; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Signal Transduction; Transforming Growth Factor beta; Ubiquitin-Activating Enzymes | 2010 |
Tumor growth inhibition of metastatic nasopharyngeal carcinoma cell lines by low dose of arsenic trioxide via alteration of cell cycle progression and induction of apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma; Caspase 3; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, Inbred BALB C; Nasopharyngeal Neoplasms; Oxides; Xenograft Model Antitumor Assays | 2011 |
Radiosensitivity enhancement by arsenic trioxide in conjunction with hyperthermia in the EC-1 esophageal carcinoma cell line.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Esophageal Neoplasms; Humans; Hyperthermia, Induced; Inhibitory Concentration 50; Oxides; Radiation Tolerance; Radiotherapy Dosage | 2012 |
ABT-737 synergizes with arsenic trioxide to induce apoptosis of gastric carcinoma cells in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Biphenyl Compounds; Carcinoma; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nitrophenols; Oxides; Piperazines; Stomach Neoplasms; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
SnoN/SkiL expression is modulated via arsenic trioxide-induced activation of the PI3K/AKT pathway in ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Drug Resistance, Neoplasm; Enzyme Inhibitors; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Neoplasm Proteins; Ovarian Neoplasms; Oxides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; RNA Interference; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; src-Family Kinases | 2013 |
Radiofrequency ablation: Effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model.
Topics: Adrenergic Agonists; Anesthetics, Inhalation; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Catheter Ablation; Disease Models, Animal; Epinephrine; Halothane; Kidney; Kidney Neoplasms; Laser-Doppler Flowmetry; Liver; Liver Neoplasms; Oxides; Rabbits; Regional Blood Flow | 2004 |
Arsenic trioxide (As2O3) sensitivity of carcinoma cell lines and cancer cells from patients with carcinomatosis peritonei.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Cell Survival; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oxides; Peritoneal Neoplasms; Xenograft Model Antitumor Assays | 2004 |
Effect of arsenic trioxide (ATO) on human lung carcinoma PG cell line: ATO induced apoptosis of PG cells and decreased expression of Bcl-2, Pgp.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Immunohistochemistry; In Vitro Techniques; Lung Neoplasms; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microscopy, Phase-Contrast; Oxides; Proto-Oncogene Proteins c-bcl-2; Time Factors | 2004 |
Arsenic trioxide induces gallbladder carcinoma cell apoptosis via downregulation of Bcl-2.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma; Down-Regulation; Gallbladder Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Oxides; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2006 |
Arsenic trioxide-mediated growth inhibition in gallbladder carcinoma cells via down-regulation of Cyclin D1 transcription mediated by Sp1 transcription factor.
Topics: Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Cyclin D1; Down-Regulation; Gallbladder Neoplasms; Humans; Oxides; Sp1 Transcription Factor; Transcription, Genetic; Transfection | 2007 |
Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis.
Topics: Acetylcysteine; Actins; Anoikis; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Emodin; Free Radical Scavengers; Humans; Oxidative Stress; Oxides; Protein Kinase Inhibitors; Reactive Oxygen Species; rhoA GTP-Binding Protein; Stomach Neoplasms; Transfection | 2008 |
Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3).
Topics: Animals; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Female; HeLa Cells; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Oxides; Radiation-Sensitizing Agents; Treatment Outcome; Tumor Stem Cell Assay; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2002 |